# PRRX1

## Overview
PRRX1 is a gene that encodes the paired related homeobox 1 protein, a transcription factor characterized by a homeodomain, which is a DNA-binding motif essential for its regulatory functions. This protein is categorized as a homeobox transcription factor and plays a pivotal role in embryonic development and cellular differentiation. The PRRX1 gene produces two isoforms, PRRX1a and PRRX1b, which differ in their C-terminal regions and have distinct roles in modulating gene expression. PRRX1 is highly expressed in mesenchymal tissues during embryogenesis and is crucial for normal craniofacial and limb development. It also participates in the epithelial to mesenchymal transition, a process vital for cardiac development and the formation of great vessels. Beyond its developmental roles, PRRX1 is involved in various pathological conditions, including cancer progression and atrial fibrillation, highlighting its significance in both physiological and pathological contexts (Takihira2024PRRX1TOP2A; Norris2000Human; Tucker2017Diminished).

## Structure
The PRRX1 gene encodes a transcription factor with a homeodomain, which is a DNA-binding motif crucial for its function. The protein exists in two isoforms, PRRX1a and PRRX1b, which differ in their C-terminal regions. PRRX1a is the canonical transcript, encoding a 245-amino-acid protein, while PRRX1b encodes a 217-amino-acid protein. Both isoforms share an identical sequence from the N terminus to amino acid 199, which includes the homeobox domain (amino acids 94-153) (Reichert2013The). The OAR domain, present in PRRX1a but absent in PRRX1b, is involved in modifying transactivation ability and is evolutionarily conserved among paired type homeoproteins (Norris2001The; Reichert2013The).

The primary structure of PRRX1 includes these specific domains, while the secondary structure likely involves common motifs such as alpha helices and beta sheets, typical of homeodomain proteins. The tertiary structure would encompass the overall 3D conformation necessary for DNA binding and interaction with other proteins. PRRX1 does not have a quaternary structure involving multiple subunits, as it functions as a single polypeptide chain. The protein may undergo post-translational modifications, although specific modifications are not detailed in the provided context. The presence of different splice variant isoforms affects the protein's function and interactions, particularly in processes like pancreatic regeneration and carcinogenesis (Reichert2013The).

## Function
The PRRX1 gene encodes a transcription factor that plays a critical role in cellular differentiation and embryonic development in vertebrates. It is involved in the regulation of gene expression by interacting with other transcription factors such as serum response factor (SRF) and TFII-I, which are crucial for transcriptional control (Norris2000Human). PRRX1 is highly expressed in mesenchymal tissues, including the heart, skeletal muscle, kidney, and lung, particularly during embryonic development. In adults, its expression is notably higher in skeletal muscle compared to other tissues (Norris2000Human).

The gene is essential for normal craniofacial and limb development, as evidenced by the phenotypes observed in Prrx1 knockout mice, which exhibit craniofacial defects and limb abnormalities (Norris2000Human). PRRX1 also plays a role in the epithelial to mesenchymal transition, a process important for cardiac development and the formation of great vessels (Tucker2017Diminished).

In addition to its developmental roles, PRRX1 is involved in inhibiting adipogenesis by activating transforming growth factor-β (TGFβ) signaling, which affects adipocyte differentiation and function (Du2013The). This regulatory function highlights its importance in maintaining cellular differentiation and tissue homeostasis.

## Clinical Significance
Mutations and altered expression of the PRRX1 gene are associated with several diseases and conditions. In malignant peripheral nerve sheath tumors (MPNST), high PRRX1 expression correlates with poor prognosis, lower 5-year survival rates, and increased metastasis, particularly to the lungs (Takihira2024PRRX1TOP2A). In osteosarcoma, PRRX1 promotes malignant properties such as migration, invasion, and tumor growth. Knockdown of PRRX1 in osteosarcoma cells reduces these malignant characteristics, suggesting its role in tumor progression (Joko2021PRRX1).

In hepatocellular carcinoma (HCC), PRRX1 downregulation is linked to mesenchymal-epithelial transition (MET) and is associated with shorter disease-free and overall survival. This downregulation promotes metastasis and tumor growth (Chen2021PRRX1). In colorectal cancer, PRRX1 expression is linked to metastasis and poor prognosis, indicating its role as an EMT inducer (Takahashi2013Paired).

PRRX1 is also implicated in atrial fibrillation (AF), where diminished expression is associated with increased risk and shortening of the cardiac action potential (Tucker2017Diminished). Mutations in PRRX1 can lead to craniofacial malformations, such as agnathia-otocephaly, due to loss of function mutations (Dasouki2013Recurrent).

## Interactions
PRRX1, a transcription factor, is involved in several protein interactions that influence cancer progression and cellular differentiation. In malignant peripheral nerve sheath tumors (MPNST), PRRX1 interacts with topoisomerase 2 alpha (TOP2A). This interaction promotes epithelial-mesenchymal transition (EMT) and enhances the expression of genes related to tumor malignancy, such as mTORC1, KRAS, and SRC signaling pathways. The PRRX1-TOP2A complex is significant in promoting malignancy, as evidenced by increased migration capacity and changes in oncogenic-related pathways (Takihira2024PRRX1TOP2A).

In the context of stromal fibroblasts, PRRX1 forms a complex with Smad3, which is crucial for TGF-β signaling. This interaction is significant for the induction of myofibroblastic phenotypes, enhancing fibronectin deposition and cell polarity alignment in response to TGF-β (Lee2022PRRX1). In glioma, PRRX1 interacts with the TGF-β/smad signaling pathway, promoting stemness and angiogenesis. It upregulates proangiogenic factors and stemness-related genes by activating this pathway, which is crucial for glioma progression (Chen2021Prrx1).

These interactions highlight PRRX1's role in various cellular processes and its potential as a therapeutic target in cancer treatment.


## References


[1. (Dasouki2013Recurrent) Majed Dasouki, Brian Andrews, Prabhu Parimi, and Deepak Kamnasaran. Recurrent agnathia–otocephaly caused by dna replication slippage in prrx1. American Journal of Medical Genetics Part A, 161(4):803–808, February 2013. URL: http://dx.doi.org/10.1002/ajmg.a.35879, doi:10.1002/ajmg.a.35879. This article has 26 citations.](https://doi.org/10.1002/ajmg.a.35879)

[2. (Joko2021PRRX1) Ryoji Joko, Daisuke Yamada, Masahiro Nakamura, Aki Yoshida, Shota Takihira, Tomoka Takao, Ming Lu, Kohei Sato, Tatsuo Ito, Toshiyuki Kunisada, Eiji Nakata, Toshifumi Ozaki, and Takeshi Takarada. Prrx1 promotes malignant properties in human osteosarcoma. Translational Oncology, 14(1):100960, January 2021. URL: http://dx.doi.org/10.1016/j.tranon.2020.100960, doi:10.1016/j.tranon.2020.100960. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.tranon.2020.100960)

[3. (Takahashi2013Paired) Y Takahashi, G Sawada, J Kurashige, R Uchi, T Matsumura, H Ueo, Y Takano, S Akiyoshi, H Eguchi, T Sudo, K Sugimachi, Y Doki, M Mori, and K Mimori. Paired related homoeobox 1, a new emt inducer, is involved in metastasis and poor prognosis in colorectal cancer. British Journal of Cancer, 109(2):307–311, June 2013. URL: http://dx.doi.org/10.1038/bjc.2013.339, doi:10.1038/bjc.2013.339. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/bjc.2013.339)

[4. (Tucker2017Diminished) Nathan R. Tucker, Elena V. Dolmatova, Honghuang Lin, Rebecca R. Cooper, Jiangchuan Ye, William J. Hucker, Heather S. Jameson, Victoria A. Parsons, Lu-Chen Weng, Robert W. Mills, Moritz F. Sinner, Maxim Imakaev, Jordan Leyton-Mange, Gus Vlahakes, Emelia J. Benjamin, Kathryn L. Lunetta, Steven A. Lubitz, Leonid Mirny, David J. Milan, and Patrick T. Ellinor. Diminished prrx1 expression is associated with increased risk of atrial fibrillation and shortening of the cardiac action potential. Circulation: Cardiovascular Genetics, October 2017. URL: http://dx.doi.org/10.1161/CIRCGENETICS.117.001902, doi:10.1161/circgenetics.117.001902. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1161/CIRCGENETICS.117.001902)

[5. (Lee2022PRRX1) Keun-Woo Lee, So-Young Yeo, Jeong-Ryeol Gong, Ok-Jae Koo, Insuk Sohn, Woo Yong Lee, Hee Cheol Kim, Seong Hyeon Yun, Yong Beom Cho, Mi-Ae Choi, Sugyun An, Juhee Kim, Chang Ohk Sung, Kwang-Hyun Cho, and Seok-Hyung Kim. Prrx1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression. Nature Communications, May 2022. URL: http://dx.doi.org/10.1038/s41467-022-30484-4, doi:10.1038/s41467-022-30484-4. This article has 35 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-30484-4)

[6. (Norris2001The) Russell A. Norris and Michael J. Kern. The identification of prx1 transcription regulatory domains provides a mechanism for unequal compensation by theprx1 and prx2 loci. Journal of Biological Chemistry, 276(29):26829–26837, July 2001. URL: http://dx.doi.org/10.1074/JBC.M100239200, doi:10.1074/jbc.m100239200. This article has 78 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M100239200)

[7. (Reichert2013The) Maximilian Reichert, Shigetsugu Takano, Johannes von Burstin, Sang-Bae Kim, Ju-Seog Lee, Kaori Ihida-Stansbury, Christopher Hahn, Steffen Heeg, Günter Schneider, Andrew D. Rhim, Ben Z. Stanger, and Anil K. Rustgi. The prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes &amp; Development, 27(3):288–300, January 2013. URL: http://dx.doi.org/10.1101/gad.204453.112, doi:10.1101/gad.204453.112. This article has 97 citations.](https://doi.org/10.1101/gad.204453.112)

[8. (Chen2021Prrx1) Zetao Chen, Yihong Chen, Yan Li, Weidong Lian, Kehong Zheng, Yuxuan Zhang, Yujie Zhang, Chuang Lin, Chaoqun Liu, Fei Sun, Xinlin Sun, Jihui Wang, Liang Zhao, and Yiquan Ke. Prrx1 promotes stemness and angiogenesis via activating tgf-β/smad pathway and upregulating proangiogenic factors in glioma. Cell Death &amp; Disease, June 2021. URL: http://dx.doi.org/10.1038/s41419-021-03882-7, doi:10.1038/s41419-021-03882-7. This article has 28 citations.](https://doi.org/10.1038/s41419-021-03882-7)

[9. (Takihira2024PRRX1TOP2A) Shota Takihira, Daisuke Yamada, Tatsunori Osone, Tomoka Takao, Masakiyo Sakaguchi, Michiyuki Hakozaki, Takuto Itano, Eiji Nakata, Tomohiro Fujiwara, Toshiyuki Kunisada, Toshifumi Ozaki, and Takeshi Takarada. Prrx1-top2a interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumours. British Journal of Cancer, 130(9):1493–1504, March 2024. URL: http://dx.doi.org/10.1038/s41416-024-02632-8, doi:10.1038/s41416-024-02632-8. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41416-024-02632-8)

[10. (Du2013The) Baowen Du, William P. Cawthorn, Alison Su, Casey R. Doucette, Yao Yao, Nahid Hemati, Sarah Kampert, Colin McCoin, David T. Broome, Clifford J. Rosen, Gongshe Yang, and Ormond A. MacDougald. The transcription factor paired-related homeobox 1 (prrx1) inhibits adipogenesis by activating transforming growth factor-β (tgfβ) signaling. Journal of Biological Chemistry, 288(5):3036–3047, February 2013. URL: http://dx.doi.org/10.1074/jbc.M112.440370, doi:10.1074/jbc.m112.440370. This article has 84 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M112.440370)

[11. (Norris2000Human) Russell A. Norris, Karen K. Scott, Clara S. Moore, Gail Stetten, Cuyler R. Brown, Ethylin Wang Jabs, Eric A. Wulfsberg, Jack Yu, and Michael J. Kern. Human prrx1 and prrx2 genes: cloning, expression, genomic localization, and exclusion as disease genes for nager syndrome. Mammalian Genome, 11(11):1000–1005, November 2000. URL: http://dx.doi.org/10.1007/s003350010193, doi:10.1007/s003350010193. This article has 40 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s003350010193)

[12. (Chen2021PRRX1) Weibo Chen, Junyi Wu, Weiwei Shi, Guang Zhang, Xuemin Chen, Anlai Ji, Zhongxia Wang, Junhua Wu, and Chunping Jiang. Prrx1 deficiency induces mesenchymal‐epithelial transition through pitx2/mir‐200–dependent slug/ctnnb1 regulation in hepatocellular carcinoma. Cancer Science, 112(6):2158–2172, April 2021. URL: http://dx.doi.org/10.1111/cas.14853, doi:10.1111/cas.14853. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cas.14853)